Document Type: Letter to the Editor

Authors

Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

-

Keywords

  1. Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, et al. Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience. Muscle Nerve 2010; 41(3): 370-4.
  2. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003; 126(Pt 10): 2304-11.
  3. Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011; 44(1): 36-40.
  4. Lavrnic D, Losen M, Vujic A, De BM, Hajdukovic LJ, Stojanovic V, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005; 76(8):
    1099-102.
  5. Punga AR, Flink R, Askmark H, Stalberg EV. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle Nerve 2006; 34(1): 111-5.
  6. Shin HY, Park HJ, Lee HE, Choi YC, Kim SM. Clinical and Electrophysiologic responses to acetylcholinesterase inhibitors in musk-antibody-positive myasthenia gravis: Evidence for cholinergic neuromuscular hyperactivity. J Clin Neurol 2014; 10(2): 119-24.
  7. van Dijk JG, Lammers GJ, Wintzen AR, Molenaar PC. Repetitive CMAPs: Mechanisms of neural and synaptic genesis. Muscle Nerve 1996; 19(9): 1127-33.